Daily News Podcast

Cardiovascular risk with diclofenac


 

Diclofenac has emerged as a clear culprit in higher risk for adverse cardiovascular events. Also today, the majority of e-cigarette users are under 35 years of age, a hospital dropped length of stay for neonatal abstinence syndrome, and physician groups continue to call for CMS to drop evaluation and management proposal.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

An epidemic of non-alcoholic fatty liver disease
MDedge Rheumatology
Sleepio app tied to reducing insomnia, depression
MDedge Rheumatology
5 digital HIPAA myths
MDedge Rheumatology
Screen for cervical cancer based on age, risk
MDedge Rheumatology
Is it time for PCPs to take over chronic HCV?
MDedge Rheumatology
Rivaroxaban data abound at ESC 2018
MDedge Rheumatology
New MI definition for infarction vs injury
MDedge Rheumatology
Lorcaserin shows cardiovascular safety
MDedge Rheumatology
Lung function decline linked to cardiovascular risk
MDedge Rheumatology
Modest alcohol and NAFLD
MDedge Rheumatology